• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 200NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 200NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500320E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Hypersensitivity/Allergic reaction (1907); Chills (2191)
Event Date 08/19/2022
Event Type  Injury  
Event Description
It was reported that a hemodialysis (hd) patient experienced chills, aches, and a fever of 104°.During treatment utilizing the optiflux 200nre dialyzer.It was believed that the patient had a dialyzer reaction.The patient was transported to the hospital via ambulance.The patient was hospitalized for three days prior to being discharged.Attempts to obtain additional information were unsuccessful.
 
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.  clinical investigation: based on the available information, there is a temporal and a likely causal relationship between the fresenius optiflux 200nre dialyzer and the patient¿s reaction (characterized by chills, aches, and a fever of 104°).Although rare, hypersensitivity or anaphylactoid reactions to dialyzers are a known risk during hemodialysis.The exposure of the patient¿s blood to a foreign substance present in the extracorporeal circuit is the result of an immunoallergic response.There is no information as to whether or not the patient switched dialyzers or if the patient requires any medical intervention prior to receiving hd treatment.There is no evidence of an optiflux 200nre dialyzer product deficiency or malfunction.Additionally, although the patient experienced an adverse reaction during treatment, there is no allegation of a product malfunction or deficiency related to this event.
 
Event Description
It was reported that a hemodialysis (hd) patient experienced chills, aches, and a fever of 104°.During treatment utilizing the optiflux 200nre dialyzer.It was believed that the patient had a dialyzer reaction.The patient was transported to the hospital via ambulance.The patient was hospitalized for three days prior to being discharged.Attempts to obtain additional information were unsuccessful.
 
Manufacturer Narrative
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.The optiflux dialyzer instruction for use indicates the following: ¿in rare cases, thrombocytopenia or hypersensitivity reactions including anaphylactic or anaphylactoid reactions to the dialyzer, or other elements in the extracorporeal circuit, may occur during hemodialysis.Hypersensitivity reactions may cause mild to severe signs and symptoms, including itching, flushing, hives, swelling, fever, leukopenia, hypotension, hypertension, shortness of breath with wheezing, arrhythmias, and/or respiratory arrest.Patients with a history of hypersensitivity reactions or patients who have a history of being highly sensitive and allergic to a variety of substances should be carefully monitored during treatment.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 200NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key15455863
MDR Text Key300243186
Report Number0001713747-2022-00367
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100163
UDI-Public00840861100163
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 11/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number0500320E
Device Catalogue Number0500320E
Device Lot Number22EU04016
Was Device Available for Evaluation? No
Device AgeMO
Initial Date Manufacturer Received 09/09/2022
Initial Date FDA Received09/20/2022
Supplement Dates Manufacturer Received10/28/2022
Supplement Dates FDA Received11/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age39 YR
Patient SexMale
Patient Weight82 KG
Patient EthnicityHispanic
-
-